GV-971 Sodium Oligomannate Capsule
NMPA Class I new drug
-
First-in-class new drug with a whole new mechanism, which targets gut microbiota and inhibits neuroinflammation1,2
-
Fast-acting, sustained-improving cognitive function in patients with Alzheimer's disease, safe and well tolerated, convenient oral administration2,3
-
A drug that is symptom-improving and potentially disease-modifying3
Highlights of prescribing information2
[Names]
Generic name：Sodium Oligomannate Capsule
Brand Name：九期一®
[Indications]
Indicated for mild to moderate Alzheimer's disease and improves cognitive function in patients
[Dosage and administration]
p.o., 3 capsules (450 mg) b.i.d. Take on an empty stomach or with food
[Adverse reactions]
See the insert for details
[Contraindications]
Contraindicated in patients with allergy to Sodium Oligomannate or any excipients of the product
[Storage]
Sealed and kept under 25℃
[Shelf life]
24 months
[Approval number]
NMPA Approval No. H20190031
[Manufacturer]
Marketing authorization holder：
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Registered address：
Room 203, Section 102, Building 6, No. 393.421 Niudun Road, China (Shanghai) Pilot Free Trade Zone
Post code：
201203
Telephone：
4008678686
Website：
www.greenvalleypharma.com
Manufacturer：
Shanghai Green Valley Pharmaceutical Co., Ltd.
Manufactory address：
886 Huijin Road, Qingpu District, Shanghai
Telephone：
021-69219666
Please read the product leaflet carefully before prescribing
References:
1. Wang X,et al.Cell Res.2019 Oct:29(10):787-803.
2.九期一®GV-971 insert (Last edited 29/09/2021)
3. SF Xiao, et al.Alzheimers Res Ther.2021 Mar 17;13(1):62.
This information is strictly for medical and scientific reference only
It is not recommended to use this product in any way that is inconsistent with the approved prescribing information
